Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
The Canadian Journal of Cardiology|August 26, 1998
Ten-year blood pressure trends in nonhypertensive inhabitants of La Plata, ArgentinaH A Carbajal, M R Salazar, B Riondet, et al.Cirugia Pediatrica : Organo Oficial De La Sociedad Espanola De Cirugia Pediatrica|July 1, 1989
[Wilms' tumor in patients with different abnormalities]J I Ruiz Jiménez, F Rodrigo García, A Gutiérrez Macías, et al.Journal of Interventional Cardiology|July 29, 2017
Safety and efficacy of percutaneous intramyocardial bone marrow cell injection for chronic myocardial ischemia: Long-term resultsSander F Rodrigo, Imke Mann, Jan van Ramshorst, et al.Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 16, 2011
Treatment options in end-stage heart failure: where to go from here?M L A Haeck, G E Hoogslag, S F Rodrigo, et al.The International Journal of Cardiovascular Imaging|February 1, 2014
Effect of intramyocardial bone marrow-derived mononuclear cell injection on cardiac sympathetic innervation in patients with chronic myocardial ischemiaJan van Ramshorst, Saskia L M A Beeres, Sander F Rodrigo, et al.American Heart Journal|November 10, 2012
Intramyocardial injection of bone marrow mononuclear cells in chronic myocardial ischemia patients after previous placebo injection improves myocardial perfusion and anginal symptoms: an intra-patient comparisonSander F Rodrigo, Jan van Ramshorst, Saskia L Beeres, et al.Circulation. Cardiovascular Interventions|August 12, 2015
Repeated Intramyocardial Bone Marrow Cell Injection in Previously Responding Patients With Refractory Angina Again Improves Myocardial Perfusion, Anginal Complaints, and Quality of LifeImke Mann, Sander F Rodrigo, Jan van Ramshorst, et al.International Journal of Cardiology|July 16, 2014
Predictors of response to intramyocardial bone marrow cell treatment in patients with refractory angina and chronic myocardial ischemiaSander F Rodrigo, Jan van Ramshorst, Imke Mann, et al.Journal of Cardiovascular Translational Research|August 29, 2013
Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells in acute myocardial infarction patients is feasible and safe up to 5 years of follow-upSander F Rodrigo, Jan van Ramshorst, Georgette E Hoogslag, et al.Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 18, 2020
Recommendations on how to provide cardiac rehabilitation services during the COVID-19 pandemicH M C Kemps, R W M Brouwers, M J Cramer, et al.Pageof 6